• Product nameAnti-ATP6V1B1 antibody
    See all ATP6V1B1 primary antibodies
  • Description
    Rabbit polyclonal to ATP6V1B1
  • Tested applicationsSuitable for: WB, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse
  • Immunogen

    Synthetic peptide derived from the C terminal of Human ATP6V1B1.

  • Positive control
    • Human breast carcinoma tissue; Extracts from HepG2 cells



Our Abpromise guarantee covers the use of ab110752 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/1000. Predicted molecular weight: 57 kDa.
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.


  • FunctionNon-catalytic subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells.
  • Tissue specificityExpressed in the cochlea and endolymphatic sac.
  • Involvement in diseaseDefects in ATP6V1B1 are the cause of distal renal tubular acidosis with deafness (dRTA-D) [MIM:267300]. Inheritance is autosomal recessive. Patients with recessive dRTA are severely affected, presenting with either acute illness or growth failure at a young age, and bilateral sensorineural deafness. Other features include low serum K(+) due to renal potassium wasting, and elevated urinary calcium. If untreated, this acidosis may result in dissolution of bone, leading to osteomalacia and rickets. Renal deposition of calcium salts (nephrocalcinosis) and renal stone formation commonly occur.
  • Sequence similaritiesBelongs to the ATPase alpha/beta chains family.
  • DomainThe PDZ-binding motif mediates interactions with SLC9A3R1 and SCL4A7.
  • Cellular localizationEndomembrane system. Endomembrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • Atp6b1 antibody
    • ATP6V1B1 antibody
    • ATPase, H+ transporting, lysosomal (vacuolar proton pump), beta 56/58 kDa, isoform 1 antibody
    • ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B, isoform 1 antibody
    • ATPase, H+ transporting, V1 subunit B, isoform 1 antibody
    • Endomembrane proton pump 58 kDa subunit antibody
    • H(+) transporting two sector ATPase 58kD subunit antibody
    • H+ ATPase beta 1 subunit antibody
    • kidney isoform antibody
    • Lysosomal 56/58kDa antibody
    • MGC32642 antibody
    • RTA1B antibody
    • V ATPase B1 subunit antibody
    • V type proton ATPase subunit B kidney isoform antibody
    • V type proton ATPase subunit B, kidney isoform antibody
    • V-ATPase subunit B 1 antibody
    • V-type proton ATPase subunit B antibody
    • Vacuolar proton pump 3 antibody
    • Vacuolar proton pump subunit 3 antibody
    • Vacuolar proton pump subunit B 1 antibody
    • VATB antibody
    • VATB1_HUMAN antibody
    • VMA2 antibody
    • Vpp 3 antibody
    • Vpp3 antibody
    see all

Anti-ATP6V1B1 antibody images

  • ab110752, at 1/50 dilution, staining ATP6V1B1 in paraffin-embedded Human breast carcinoma tissue. Right panel is also in the presence of immunising peptide.
  • All lanes : Anti-ATP6V1B1 antibody (ab110752) at 1/500 dilution

    Lane 1 : Extracts from HepG2 cells
    Lane 2 : Extracts from HepG2 cells with immunising peptide at 10 µg

    Lysates/proteins at 30 µg per lane.

    Predicted band size : 57 kDa

References for Anti-ATP6V1B1 antibody (ab110752)

ab110752 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab110752.
Please use the links above to contact us or submit feedback about this product.